Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema
- 30 April 1987
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 16 (4), 797-804
- https://doi.org/10.1016/s0190-9622(87)70104-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and safety of astemizole, a long-acting and nonsedating H antagonist for the treatment of chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 1986
- 248 Astemizole, a H1-antagonist, in allergic asthmaJournal of Allergy and Clinical Immunology, 1985
- 249 Treatment of chronic idiopathic urticaria (CIU) with astemizole (A)Journal of Allergy and Clinical Immunology, 1985
- 102 Efficacy of astemizole (AST) for the treatment of chronic idiopathic urticaria (CIU)Journal of Allergy and Clinical Immunology, 1985
- AstemizoleDrugs, 1984
- Treatment of chronic idiopathic urticaria with terfenadineClinical and Experimental Allergy, 1984
- Urticaria and angioedemaJournal of Allergy and Clinical Immunology, 1983
- Delayed pressure urticariaJournal of Allergy and Clinical Immunology, 1982
- Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.British Journal of Clinical Pharmacology, 1982